Abiopharma

🔍 McMullen Michael R. (Director)

Company: BRISTOL MYERS SQUIBB CO (BMY)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 577 shares of Deferred Share Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,556.77 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2

Footnotes:

• F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
• F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.